Ligand · D13

D13 · 4-[5-(3-iodo-phenyl)-2-(4-methanesulfinyl-phenyl)-1H-imidazol-4-yl]-pyridine

D13, 4-[5-(3-iodo-phenyl)-2-(4-methanesulfinyl-phenyl)-1H-imidazol-4-yl]-pyridine (C21 H16 I N3 O S, 485.3 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å…

Component: D13
Formula: C21 H16 I N3 O S
Class: ligand
Structures: 2
PDB entries: 1

Binding sites

D13 in 2 structures; the first of them:

1IAN · Human P38 MAP kinase inhibitor complex · D13 A391 · binds ALA51, VAL52, LYS53, LEU108, MET109
1IAN · Human P38 MAP kinase inhibitor complex · D13 A391 · binds ALA51, VAL52, LYS53, LEU108, MET109

Residues it binds most

ALA 4, LEU 4, SER 4, ASN 2, ASP 2, GLU 2, ILE 2, LYS 2, MET 2, TRP 2 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.